C Cowboyjim Well-Known Member Messages 1,294 Apr 16, 2010 #1 Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. http://www.inpharm.com/news/lixisenatide-scores-phase-iii-trial
Sanofi-Aventis’ novel, once-daily diabetes treatment lixisenatide has successfully met its phase III glucose blood level and glycaemic control endpoints. http://www.inpharm.com/news/lixisenatide-scores-phase-iii-trial
noblehead Guru Retired Moderator Messages 23,618 Type of diabetes Type 1 Treatment type Pump Dislikes Disrespectful people Apr 16, 2010 #2 Interesting developments Cowboy! It would be interesting to know what diet the participants followed with regards to daily carb intake. Nigel
Interesting developments Cowboy! It would be interesting to know what diet the participants followed with regards to daily carb intake. Nigel
C Cowboyjim Well-Known Member Messages 1,294 Apr 16, 2010 #3 Ah the vagaries of science as applied to humans... it must be fun trying to get a sufficiently large sample of humes and ensure they don't 'cheat'! 8)
Ah the vagaries of science as applied to humans... it must be fun trying to get a sufficiently large sample of humes and ensure they don't 'cheat'! 8)